Most of the currently reported ATP1A3 mutations are either associated with AHC or RDP, but it is possible that the same ATP1A3 pathogenic mutations may lead to different phenotypes (Roubergue et al., 2013; Boelman et al., 2014). This evidence concerns the gene ATP1A3 and dystonia 12.